ENTITY
Shanghai Bio-heart Biological Technology

Shanghai Bio-heart Biological Technology (2185 HK)

19
Analysis
IndustrialsChina
Shanghai Bio-heart Biological Technology is an interventional cardiovascular device company that develops innovative therapies for unmet medical needs in the treatment of coronary artery disease and hypertension. Its key products include the Bioheart bioresorbable scaffolds (BRS) system, the Iberis 2nd renal denervation (RDN) product candidate, and drug-coated balloons (DCB). The company was founded in 2014 and is headquartered in Shanghai, People's Republic of China.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x